Pharmaceutical Market Europe • May 2024 • 47
APPOINTMENTS
UCB
Alistair Henry
UCB has appointed Alistair Henry as chief scientific officer. Henry, who is a biophysicist by background, joins the executive committee with extensive experience within the pharmaceutical industry. He has most recently been serving as head of UK research at UCB and has held a variety of roles during his 26 years at the company, including senior director and head of discovery science. Henry has worked on multiple therapeutic programmes throughout his time at UCB, including Cimzia (certolizumab pegol), Evenity (romosozumab-aqqg) and Bimzelx (bimekizumab), and is noted to have helped champion the use of advanced biophysical methodologies to support discovery and understanding of drugs and the biological systems they interact with. Prior to joining UCB, Henry was a postdoctoral research fellow at King’s College London.
The British In Vitro Diagnostic Association
Helen Dent
The British In Vitro Diagnostic Association (BIVDA) has appointed Helen Dent as CEO. Dent has over two decades of industry experience and takes on the role after serving as the association’s interim CEO. Prior to joining BIVDA as chief operating officer, she worked at a senior level at Abbott Diagnostics in the UK and Europe.
Chiesi USA
Richard Smith
Chiesi USA has appointed Richard Smith as vice president and business unit leader of US AIR. Smith holds 25 years of experience and joins Chiesi from LEO Pharma, where he was vice president and head of US the company’s commercial organisation. Smith has also held roles at Aimmune Therapeutics, EMD Serono and Novartis.
Recursion
Najat Khan
Recursion has appointed Najat Khan as chief research and development officer and chief commercial officer. Khan joins from her role as chief data science officer and global head of strategy and portfolio organisation for innovative medicine R&D at Johnson & Johnson. Khan is also the founder and co-chair of the Data Science in Industry Roundtable.
Calluna Pharma
Margrethe Sørgaard
Calluna Pharma has appointed Margrethe Sørgaard as senior vice president of clinical operations and pharmacovigilance. Sørgaard joins the company from BioInvent International, where she was senior director of safety pharmacovigilance. Prior to BioInvent, she served in a number of positions at Circio, including as vice president and head of clinical development.
insitro
Amy Abernethy
insitro has appointed Amy Abernethy to its board of directors. Abernethy most recently served as president of product development and chief medical officer at Verily. She was also previously principal deputy commissioner of food and drugs for the FDA and chief medical officer, chief scientific officer and senior vice president for oncology at Flatiron Health.
Genomtec
Trevor Hawkins
Genomtec has appointed Trevor Hawkins to its supervisory board. Hawkins brings extensive experience to the role, having served as director of the Human Genome Project at the US Department of Energy and in leadership roles at Philips and Siemens and GE. He also sits on a number of boards, including for Resistell and Noscendo.
Polaroid Therapeutics
Markus Rothmaier
Polaroid Therapeutics has appointed Markus Rothmaier as head of research and development. Rothmaier has over two decades of pharmaceutical R&D leadership experience and joins Polaroid from his most recent role as head of R&D at IVF Hartmann. Prior to this, Rothmaier held a range of roles at Empa, Sensorix and ETH Zurich.
Clearside Biomedical
Anthony Gibney
Clearside Biomedical has appointed Anthony Gibney to its board of directors. Gibney most recently served as executive vice president, chief business and strategy officer at Iveric Bio. Prior to this, Gibney was chief financial officer and chief business officer at Fog Pharmaceuticals and executive vice president and chief business officer at Achillion Pharmaceuticals.
Pharmaceutical Market Europe (PME)
Pharmaceutical industry news, articles, jobs, reports, advice and services